Stephens Inc Pacira Bio Sciences, Inc. Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $148,804 - $190,598	-5,372 Reduced 52.09%	4,940 $144,000
Q4 2023 Feb 13, 2024	SELL	$26.32 - $34.31 $9,106 - $11,871	-346 Reduced 3.25%	10,312 $347,000
Q3 2023 Nov 14, 2023	SELL	$30.68 - $40.09 $1,595 - $2,084	-52 Reduced 0.49%	10,658 $326,000
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $8,668 - $11,400	240 Added 2.29%	10,710 $429,000
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $12,790 - $15,616	360 Added 3.56%	10,470 $427,000
Q4 2022 Jan 25, 2023	SELL	$38.19 - $57.45 $17,223 - $25,909	-451 Reduced 4.27%	10,110 $390,000
Q3 2022 Nov 02, 2022	SELL	$51.24 - $58.89 $9,274 - $10,659	-181 Reduced 1.68%	10,561 $562,000
Q2 2022 Aug 03, 2022	SELL	$51.49 - $81.64 $947,210 - $1.5 Million	-18,396 Reduced 63.13%	10,742 $626,000
Q1 2022 May 04, 2022	BUY	$60.03 - $76.49 $1.16 Million - $1.48 Million	19,352 Added 197.75%	29,138 $793,000
Q4 2021 Mar 07, 2022	SELL	$47.97 - $62.21 $23,889 - $30,980	-498 Reduced 4.84%	9,786 $589,000
Q3 2021 Oct 27, 2021	BUY	$54.64 - $61.3 $10,326 - $11,585	189 Added 1.87%	10,284 $576,000
Q2 2021 Aug 12, 2021	SELL	$59.18 - $69.99 $9,823 - $11,618	-166 Reduced 1.62%	10,095 $613,000
Q1 2021 May 14, 2021	BUY	$59.31 - $78.82 $259,066 - $344,285	4,368 Added 74.12%	10,261 $719,000
Q4 2020 Feb 10, 2021	SELL	$50.47 - $66.26 $306,605 - $402,529	-6,075 Reduced 50.76%	5,893 $353,000
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $18,397 - $22,302	-354 Reduced 2.87%	11,968 $720,000
Q2 2020 Aug 24, 2020	SELL	$30.8 - $52.47 $21,005 - $35,784	-682 Reduced 5.24%	12,322 $647,000
Q1 2020 May 14, 2020	BUY	$28.4 - $50.7 $139,160 - $248,430	4,900 Added 60.46%	13,004 $436,000
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $284,343 - $366,725	-7,831 Reduced 49.14%	8,104 $367,000
Q3 2019 Oct 18, 2019	BUY	$35.66 - $44.99 $10,234 - $12,912	287 Added 1.83%	15,935 $607,000
Q2 2019 Aug 01, 2019	SELL	$36.57 - $47.97 $5,412 - $7,099	-148 Reduced 0.94%	15,648 $681,000
Q1 2019 May 03, 2019	SELL	$36.47 - $42.17 $27,352 - $31,627	-750 Reduced 4.53%	15,796 $601,000
Q4 2018 Feb 11, 2019	SELL	$41.31 - $52.16 $134,959 - $170,406	-3,267 Reduced 16.49%	16,546 $712,000
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $650,857 - $1.03 Million	19,813 New	19,813 $974,000
Q3 2017 Nov 08, 2017	SELL	$35.7 - $39.5 $848,767 - $939,112	-23,775 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	23,775	23,775 $1.13 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

Black Rock Inc. New York, NY

8.01M
Shares

$156 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.3M
Shares

$103 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

4.96M
Shares

$96.6 Million
0.18% of portfolio
State Street Corp Boston, MA

2.01M
Shares

$39.2 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.98M
Shares

$38.5 Million
0.05% of portfolio

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account